RIM
ALNY icon

Rakuten Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Rakuten Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
17,961
+3,530
+24% +$1.06M 0.02% 272
2026
Q1 		$4.56M Buy
14,431
+1,747
+14% +$594K 0.01% 268
2025
Q4 		$5.06M Sell
12,684
-18,468
-59% -$8.17M 0.02% 275
2025
Q3 		$6.58M Buy
+31,152
New +$12.7M 0.02% 213
2025
Q1 		$955K Buy
+3,559
New +$915K ﹤0.01% 501
2024
Q3 		$636K Buy
2,314
+575
+33% +$150K ﹤0.01% 411
2024
Q2 		$430K Buy
1,739
+653
+60% +$103K ﹤0.01% 413
2024
Q1 		$162K Buy
1,086
+996
+1,107% +$166K ﹤0.01% 447
2023
Q4 		$17.6K Buy
+90
New +$15.3K ﹤0.01% 433

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rakuten Investment Management's ALNY Position: Q2 2026 in Review

Rakuten Investment Management increased its Alnylam Pharmaceuticals (ALNY) stake by 24% in Q2 2026, buying an estimated $1.06M and bringing the position to 17,961 shares worth $5.27M. The position accounts for 0.02% of the portfolio, ranked #272.

Rakuten Investment Management first reported a position in ALNY in Q4 2023 and has held it in 9 quarters since. The position peaked at $6.58M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Rakuten Investment Management held 17,961 shares of Alnylam Pharmaceuticals worth $5.27M as of Q2 2026.
  • Rakuten Investment Management bought 3,530 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.06M.
  • Alnylam Pharmaceuticals made up 0.02% of Rakuten Investment Management's portfolio in Q2 2026, its #272 holding.
  • Rakuten Investment Management first reported a position in Alnylam Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Rakuten Investment Management's Alnylam Pharmaceuticals position peaked at $6.58M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.